0910-AF25 200904 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Blood Initiative--Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use Other Significant Previously Published in The Unified Agenda Long-Term Actions No No 21 CFR 606 21 CFR 610 21 CFR 630 21 CFR 640 21 CFR 660 21 CFR 820 21 CFR 1270 21 USC 321 21 USC 331 21 USC 351 to 353 21 USC 355 21 USC 360 21 USC 360c to 360e 21 USC 360h to 360j 21 USC 360l 21 USC 371 21 USC 372 21 USC 374 21 USC 381 21 USC 383 42 USC 216 42 USC 243 42 USC 262 and 263 42 USC 263a 42 USC 264 42 USC 271 No NPRM 11/08/2007 72 FR 63416 NPRM Comment Period End 02/06/2008 NPRM Comment Period Extended 01/11/2008 73 FR 1983 NPRM Comment Period End 08/04/2008 Final Action To Be Determined No Businesses None No No No 0910-AB26 Split from Paul Levine E. 0910 Food and Drug Administration FDA 301 827-6210 Suite 200N (HFM-17), Center for Biologics Evaluation and Research, Suite 200N (HFM-17), 1401 Rockville Pike, Rockville MD 20852